ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 92 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $945,000 | +21.2% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $780,000 | -33.2% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,167,000 | +44.6% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $807,000 | -12.7% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $924,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,155,000 | +26.2% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $915,000 | -28.1% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,272,000 | +9.8% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,158,000 | -42.6% | 300 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $2,019,000 | +74.4% | 300 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $1,158,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |